Unknown

Dataset Information

0

Hanson2016 - Toxicity Management in CAR T cell therapy for B-ALL

ABSTRACT: 

This model provides an in silico mathematical platform to explore the interactions between chimeric antigen receptor-modified T cells, inflammatory toxicitiy, and the tumour burdens of individual patients.

SUBMITTER: Lucian Smith 

PROVIDER: MODEL1910250001 | biostudies-other |

SECONDARY ACCESSION(S): 10.1101/049908

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
| S-EPMC4684949 | biostudies-literature
Unknown CAR T Cell Toxicity: Current Management and Future Directions.
| S-EPMC6746032 | biostudies-literature
Unknown CAR-T Cell Therapy: the Efficacy and Toxicity Balance.
| S-EPMC10505056 | biostudies-literature
Unknown Prolonged haematologic toxicity in CAR-T-cell therapy: A review.
| S-EPMC10718150 | biostudies-literature
Unknown CAR T-Cell therapy for the management of mantle cell lymphoma.
| S-EPMC10064560 | biostudies-literature
Unknown Strain-dependent Lethal Toxicity in NKG2D Ligand-targeted CAR T-cell Therapy.
| S-EPMC4817918 | biostudies-literature
Unknown Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.
| S-EPMC8756350 | biostudies-literature
Unknown Management of aggressive lymphoma after CAR T-cell therapy failure.
| S-EPMC10727106 | biostudies-literature
Unknown Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
| S-EPMC5154474 | biostudies-literature
Unknown CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities.
| S-EPMC8250150 | biostudies-literature